{"id":5326,"date":"2024-09-30T06:18:03","date_gmt":"2024-09-30T10:18:03","guid":{"rendered":"https:\/\/cytel.agencyukdev.com\/?post_type=resource&#038;p=5326"},"modified":"2024-09-30T06:18:41","modified_gmt":"2024-09-30T10:18:41","slug":"white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design","status":"publish","type":"resource","link":"https:\/\/cytel.agencyukdev.com\/fr\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/","title":{"rendered":"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"tags":[416],"asset-type":[55],"drug-development-phases":[64,65,66,505],"service-type":[491,486,473,533,466],"therapeutic-areas":[483,469,481,474,495,488,498,476,58,57,484],"class_list":["post-5326","resource","type-resource","status-publish","hentry","tag-white-paper","asset-type-whitepapers","drug-development-phases-phase-1","drug-development-phases-phase-2","drug-development-phases-phase-3","drug-development-phases-preclinical","service-type-adaptive-trial-design","service-type-bayesian","service-type-biostatistics","service-type-east-horizon","service-type-software","therapeutic-areas-autoimmune-disease","therapeutic-areas-blood-disorder","therapeutic-areas-cardiovascular","therapeutic-areas-infectious-diseases","therapeutic-areas-liver-disease","therapeutic-areas-macular-degeneration","therapeutic-areas-neurological-disorder","therapeutic-areas-neurolomuscular-disorder","therapeutic-areas-oncology","therapeutic-areas-rare-diseases","therapeutic-areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cytel.agencyukdev.com\/fr\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cytel.agencyukdev.com\/fr\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-30T10:18:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/resource\\\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\\\/\",\"url\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/resource\\\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\\\/\",\"name\":\"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/#website\"},\"datePublished\":\"2024-09-30T10:18:03+00:00\",\"dateModified\":\"2024-09-30T10:18:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/resource\\\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cytel.agencyukdev.com\\\/resource\\\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/resource\\\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/#website\",\"url\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/\",\"name\":\"Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us\",\"description\":\"Innovative Trial Design. Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cytel.agencyukdev.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cytel.agencyukdev.com\/fr\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/","og_locale":"fr_FR","og_type":"article","og_title":"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us","og_url":"https:\/\/cytel.agencyukdev.com\/fr\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/","og_site_name":"Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us","article_modified_time":"2024-09-30T10:18:41+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cytel.agencyukdev.com\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/","url":"https:\/\/cytel.agencyukdev.com\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/","name":"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design - Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us","isPartOf":{"@id":"https:\/\/cytel.agencyukdev.com\/#website"},"datePublished":"2024-09-30T10:18:03+00:00","dateModified":"2024-09-30T10:18:41+00:00","breadcrumb":{"@id":"https:\/\/cytel.agencyukdev.com\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cytel.agencyukdev.com\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cytel.agencyukdev.com\/resource\/white-paper-exploring-treatment-effect-thresholds-in-adaptive-trial-design\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cytel.agencyukdev.com\/"},{"@type":"ListItem","position":2,"name":"White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design"}]},{"@type":"WebSite","@id":"https:\/\/cytel.agencyukdev.com\/#website","url":"https:\/\/cytel.agencyukdev.com\/","name":"Clinical Trial Software &amp; Data Analysis | Cytel | Contact Us","description":"Innovative Trial Design. Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cytel.agencyukdev.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/resource\/5326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/types\/resource"}],"wp:attachment":[{"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/media?parent=5326"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/tags?post=5326"},{"taxonomy":"asset-type","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/asset-type?post=5326"},{"taxonomy":"drug-development-phases","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/drug-development-phases?post=5326"},{"taxonomy":"service-type","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/service-type?post=5326"},{"taxonomy":"therapeutic-areas","embeddable":true,"href":"https:\/\/cytel.agencyukdev.com\/fr\/wp-json\/wp\/v2\/therapeutic-areas?post=5326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}